Enterome’s OncoMimic technology allows the overcoming of immune tolerance against cancer cells, with broad applicability against solid tumor via an off-the-shelf, easy to manufacture technology. Enterome’s potentially first-in-class small protein and peptide drug candidates modulate the immune syste... Read more
Org chart
Collapse
Teams
Offices
ARCHIMED
5 followers
M2I Life Sciences
1 follower
Laurus Bio
2 followers
Institute for Stem Cell Science and Regenerative Medicine (BRIC-inStem)
2 followers
Cure51
4 followers
Pierre Fabre
27 followers
IVX Health
3 followers
Sebia
2 followers
Truveta
5 followers
Alamar Biosciences, Inc.
2 followers
Galvanize Therapeutics, Inc.
2 followers
Aspect Biosystems
1 follower